Search
for
Sort by
Research 91–120 of 1000+
- ORAL MINOXIDIL EFFICACY AND SAFETY IN MALE ANDROGENETIC ALOPECIA - A LITERATURE REVIEW
- Investigation, Treatment, and Monitoring of Late‐Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
- SARS-CoV-2 vaccination in androgen sensitive phenotypes – A study on associated factors for SARS-CoV-2 vaccination and its adverse effects among androgenetic alopecia and benign prostate hyperplasia patients
- Postmenopausal Alopecia (Hair Loss)
- Management of Hair Loss in Women
- Impact of Hormones on Female Sexual Function and Dysfunction
- Anabolic and Metabolic Effects of Testosterone and Other Androgens: Direct Effects and Role of Testosterone Metabolic Products
- Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study
- What does the research say about androgen use and cerebrovascular events?
- PMON281 PERSISTENT VIRILIZATION AND VASOMOTOR SYMPTOMS IN A TRANSMAN 5-YEARS POST TESTOSTERONE WITHDRAWAL
- Interventions for central serous chorioretinopathy: a network meta-analysis
- Treatment of Chemotherapy Induced Alopecia
- Male and female pattern hair loss
- Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health
- Revisión actualizada del tratamiento de la alopecia androgenética femenina
- Recomendaciones sobre el manejo clínico de la alopecia androgénica: un documento de consenso del Grupo Español de Tricología de la Academia Española de Dermatología y Venereología
- Methodologic considerations in evaluating early clinical outcomes of GT20029 for androgenetic alopecia
- THE EFFECT OF SPIRONOLACTONE ON HIRSUTISM AND FEMALE ANDROGEN METABOLISM
- Cardiometabolic profile of young women with hypoprolactinemia
- Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations
- Testosterone: The Male Sex Hormone
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Teicoplanin alleviates androgenetic alopecia through inhibition of androgen receptor expression and enhancing dermal papilla cell proliferation
- Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia
- Treatment of hyperandrogenism in polycystic ovary syndrome
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Effects of non-contingent cocaine on 3alpha-androstanediol. I. Disruption of male sexual behavior
- Androgen Receptor Blockade Induces the Phagocytosis of MRSA and Pseudomonas aeruginosa by Monocyte-Derived Macrophages In Vitro